Safety Study of Tecadenoson to Treat Atrial Fibrillation
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
Assess the tolerability and safety of a rapid bolus of tecadenoson at different dose levels
when given alone and in combination with a beta-blocker (esmolol) in patients with atrial
fibrillation to control rapid heart rate. Explore the pharmacokinetic and pharmacodynamic
effects when given alone and in combination with beta-blocker (esmolol).